martes, 17 de septiembre de 2019

FDA, EMA probing carcinogen in Zantac and other heartburn meds

FDA, EMA probing carcinogen in Zantac and other heartburn meds

Cancer Briefing

FDA and EMA are now probing carcinogen in Zantac and other heartburn meds

By ED SILVERMAN


ANDREW HARNIK/AP
At issue is NDMA, an organic chemical that was once used to make rocket fuel and is an unintended by-product of certain chemical reactions.

No hay comentarios: